首页> 美国卫生研究院文献>other >Function structure and regulation of the vacuolar (H+)-ATPases
【2h】

Function structure and regulation of the vacuolar (H+)-ATPases

机译:液泡(H +)-ATPases的功能结构和调控

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The vacuolar ATPases (or V-ATPases) are ATP-driven proton pumps that function to both acidify intracellular compartments and to transport protons across the plasma membrane. Intracellular V-ATPases function in such normal cellular processes as receptor-mediated endocytosis, intracellular membrane traffic, prohormone processing, protein degradation and neurotransmitter uptake, as well as in disease processes, including infection by influenza and other viruses and killing of cells by anthrax and diphtheria toxin. Plasma membrane V-ATPases are important in such physiological processes as urinary acidification, bone resorption and sperm maturation as well as in human diseases, including osteopetrosis, renal tubular acidosis and tumor metastasis. V-ATPases are large multi-subunit complexes composed of a peripheral domain (V1) responsible for hydrolysis of ATP and an integral domain (V0) that carries out proton transport. Proton transport is coupled to ATP hydrolysis by a rotary mechanism. V-ATPase activity is regulated in vivo using a number of mechanisms, including reversible dissociation of the V1 and V0 domains, changes in coupling efficiency of proton transport and ATP hydrolysis and changes in pump density through reversible fusion of V-ATPase containing vesicles. V-ATPases are emerging as potential drug targets in treating a number of human diseases including osteoporosis and cancer.
机译:液泡ATP酶(或V-ATP酶)是ATP驱动的质子泵,其功能是酸化细胞内区室并在质膜上运输质子。细胞内V-ATPase在正常的细胞过程中起作用,例如受体介导的内吞作用,细胞内膜运输,激素激素加工,蛋白质降解和神经递质吸收,以及疾病过程,包括流行性感冒和其他病毒的感染以及炭疽和杀伤性细胞的死亡。白喉毒素。质膜V-ATP酶在诸如尿酸化,骨吸收和精子成熟的生理过程中以及在包括骨石化,肾小管酸中毒和肿瘤转移在内的人类疾病中都很重要。 V-ATPase是大型的多亚基复合物,由负责ATP水解的外围结构域(V1)和进行质子转运的完整结构域(V0)组成。质子传输通过旋转机制与ATP水解耦合。通过多种机制体内调节V-ATPase活性,包括V1和V0域的可逆解离,质子转运和ATP水解的偶联效率变化以及通过含V-ATPase的囊泡的可逆融合改变泵浦密度。 V-ATP酶正在成为治疗包括骨质疏松症和癌症在内的多种人类疾病的潜在药物靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号